Abstract

Hematopoiesis involves a series of lineage differentiation programs initiated in hematopoietic stem cells (HSCs) found in bone marrow (BM). To ensure lifelong hematopoiesis, various molecular mechanisms are needed to maintain the HSC pool. CCCTC-binding factor (CTCF) is a DNA-binding, zinc-finger protein that regulates the expression of its target gene by organizing higher order chromatin structures. Currently, the role of CTCF in controlling HSC homeostasis is unknown. Using a tamoxifen-inducible CTCF conditional knockout mouse system, we aimed to determine whether CTCF regulates the homeostatic maintenance of HSCs. In adult mice, acute systemic CTCF ablation led to severe BM failure and the rapid shrinkage of multiple c-Kithi progenitor populations, including Sca-1+ HSCs. Similarly, hematopoietic system-confined CTCF depletion caused an acute loss of HSCs and highly increased mortality. Mixed BM chimeras reconstituted with supporting BM demonstrated that CTCF deficiency-mediated HSC depletion has both cell-extrinsic and cell-intrinsic effects. Although c-Kithi myeloid progenitor cell populations were severely reduced after ablating Ctcf, c-Kitint common lymphoid progenitors and their progenies were less affected by the lack of CTCF. Whole-transcriptome microarray and cell cycle analyses indicated that CTCF deficiency results in the enhanced expression of the cell cycle-promoting program, and that CTCF-depleted HSCs express higher levels of reactive oxygen species (ROS). Importantly, in vivo treatment with an antioxidant partially rescued c-Kithi cell populations and their quiescence. Altogether, our results suggest that CTCF is indispensable for maintaining adult HSC pools, likely by regulating ROS-dependent HSC quiescence.

Highlights

  • Hematopoiesis in the human body is primarily maintained by a complex differentiation program initiated in hematopoietic stem cells (HSCs).[1]

  • Loss of CCCTC-binding factor (CTCF) leads to rapid bone marrow (BM) failure To examine the relative expression levels of Ctcf mRNA in primitive hematopoietic stem/progenitor cells, we analyzed the Immunological Genome microarray database, which includes data on a large number of immune cells and their progenitor cell populations.[29]

  • CTCF has been shown to regulate the cellular development and differentiation of human erythroid cells,[39] murine thymocytes,[25] mature T cells,[25,40] B cells[41] and myeloid lineage cells, including dendritic cell (DC),[26,27,42] whether CTCF controls the homeostasis of adult HSCs has been unknown

Read more

Summary

Introduction

Hematopoiesis in the human body is primarily maintained by a complex differentiation program initiated in hematopoietic stem cells (HSCs).[1]. Another study has demonstrated that HSC function is controlled by the mediator component MED12, which regulates H3K27Ac at enhancers of key HSC genes.[17] Further understanding how HSC homeostasis and function are maintained by other epigenetic factors could be important for developing new therapeutic strategies. Epigenetic changes have been implicated in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia.[18]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call